1. Albanese A, Stanhope R (1994) Pathogenetic mechanisms and management priorities in constitutional delay. In: Savage MO, Bourguignon JP, Grossman AB (eds) Frontiers in pae-diatric neuroendocrinology. Blackwell, Oxford, pp 33–37.
2. Angulo M, Mazur B, Vitollo P, Castro-Magana M, Canas JA, Sarrantionio M, Villarojo L (1995) Body mass index (BMI) and scoliosis in Prader-Willi syndrome (Prader-Labhart-Willi syndrome) after two years growth hormone (GH) therapy. Proceedings of the 26th Annual March of Dimes Clinical Genetics Conference and 2nd Annual Meeting of the American College of Medical Genetics, Los Angeles, p 180.
3. Baraitser M (1990) Cerebellar syndromes. In: The genetics of neurological disorders, 2nd edn. Oxford University Press, Oxford, pp 173–211.
4. Berezin M, Karasik A (1995) Familial prolactinoma. Clin Endocrinol 42:483–486.
5. Bevan JS, Webster J, Burke C, Scanlon MF (1992) Dopamine agonists and pituitary tumour shrinkage. Endocr Rev 13:220–240.